Generic medicine

Dapagliflozin 5mg Tablet

Reviewed educational reference: what Dapagliflozin is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Dapagliflozin
Strength
5mg
Dosage form
Tablet
Drug class
Sodium-glucose cotransporter 2 (SGLT2) inhibitor

Related products

No reviewed products are currently published for this generic.

Dapagliflozin 5mg Tablet contains Dapagliflozin, a potent and selective inhibitor of the sodium-glucose co-transporter 2 (SGLT2). By inhibiting this protein in the proximal renal tubules, Dapagliflozin reduces the reabsorption of filtered glucose from the tubular lumen and lowers the renal threshold for glucose. This results in increased urinary glucose excretion, which effectively lowers blood glucose levels in patients with type 2 diabetes mellitus. Beyond its glycemic control, Dapagliflozin 5mg Tablet is also indicated for the management of chronic heart failure and chronic kidney disease in specific patient populations.

At a glance

Quick look

Dapagliflozin 5mg Tablet is a sodium-glucose co-transporter 2 (SGLT2) inhibitor.

How it works

It lowers blood glucose by increasing the amount of sugar removed from the body through urine.

Who it is for

It is used to treat type 2 diabetes, heart failure, and chronic kidney disease.

Uses it for
Type 2 DiabetesHeart FailureChronic Kidney DiseaseGlycemic controlRenal protectionCardiovascular risk reduction

Uses of Dapagliflozin

  • Management of type 2 diabetes mellitus to improve glycemic control.
  • Reduction of the risk of hospitalization for heart failure in adults with heart failure.
  • Treatment of chronic kidney disease to reduce the risk of sustained eGFR decline.
  • Adjunct to diet and exercise for glycemic management.
  • Used as monotherapy or in combination with other antidiabetic agents.
  • Management of symptomatic heart failure with reduced ejection fraction.

Benefits of Dapagliflozin

Improved Glycemic Control
By promoting the excretion of excess glucose through the urine, Dapagliflozin 5mg Tablet helps maintain stable blood sugar levels throughout the day. This mechanism is independent of insulin secretion, making it a valuable option for patients who may have diminished beta-cell function.

Cardiovascular and Renal Protection
Dapagliflozin 5mg Tablet provides significant benefits beyond blood sugar management. Clinical studies demonstrate that it reduces the risk of cardiovascular death and hospitalization for heart failure. Furthermore, it slows the progression of chronic kidney disease, offering a protective effect on renal function that is essential for long-term health in patients with metabolic disorders.

Side effects of Dapagliflozin

The most common side effects associated with Dapagliflozin 5mg Tablet include genital mycotic infections, such as vulvovaginal candidiasis and balanitis, which occur due to the increased glucose concentration in the urine. Urinary tract infections are also frequently reported. Patients may experience increased urination (polyuria) and volume depletion, which can lead to symptoms like dizziness, orthostatic hypotension, or dehydration, particularly in elderly patients or those taking diuretics. Rare but serious side effects include euglycemic diabetic ketoacidosis, a condition where blood glucose levels remain near normal while ketones are elevated, requiring immediate medical attention. Fournier's gangrene, a rare necrotizing fasciitis of the perineum, has also been reported and necessitates urgent surgical intervention if suspected.

Side effectHow commonHow severeWhat to do
Genital mycotic infectionsCommonMildPractice good hygiene and keep the genital area dry.
Urinary tract infectionsCommonModerateIncrease fluid intake to flush the urinary tract.
Volume depletionUncommonModerateEnsure adequate daily water intake.

How to manage side effects

Genital mycotic infections

  • Consult a doctor for antifungal treatment.
  • Maintain daily washing.
  • Wear breathable cotton underwear.

Urinary tract infections

  • Seek medical advice for antibiotic therapy.
  • Monitor for fever or back pain.
  • Complete the full course of prescribed antibiotics.

Volume depletion

  • Monitor blood pressure regularly.
  • Rise slowly from sitting positions.
  • Report dizziness to your doctor.

How to use Dapagliflozin

  • Take Dapagliflozin 5mg Tablet orally once daily, preferably in the morning.
  • You may take the tablet with or without food.
  • Swallow the tablet whole with a full glass of water.
  • Do not crush, chew, or break the tablet.
  • Follow the exact dosage prescribed by your healthcare provider.
  • Maintain consistent hydration while taking this medication to support renal function.

Special population advice

Kidney impairment

  • Assess renal function before initiating treatment.
  • Not recommended for patients with eGFR consistently below 25 mL/min/1.73m2.
  • Dose adjustment may be required based on eGFR levels.

Liver impairment

  • No initial dose adjustment is required for mild to moderate hepatic impairment.
  • Use with caution in patients with severe hepatic impairment due to limited clinical data.

Children

  • Safety and efficacy in children under 18 years of age have not been established.
  • Not recommended for pediatric use.

Elderly

  • Use with caution due to the increased risk of volume depletion and hypotension.
  • Monitor renal function and fluid status more frequently.

How Dapagliflozin works

Dapagliflozin selectively inhibits the SGLT2 protein in the proximal convoluted tubule of the kidney. Under normal conditions, SGLT2 is responsible for reabsorbing approximately 90% of filtered glucose back into the bloodstream. By blocking this transporter, Dapagliflozin 5mg Tablet forces the kidneys to excrete excess glucose into the urine, effectively lowering blood glucose levels and providing osmotic diuresis.

What if you miss or exceed a dose?

If you miss a dose

If you miss a dose of Dapagliflozin 5mg Tablet, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time to make up for a forgotten dose, as this may increase the risk of side effects.

In case of overdose

In the event of an overdose with Dapagliflozin 5mg Tablet, seek immediate medical attention or contact a poison control center. While Dapagliflozin is generally well-tolerated, an excessive dose may lead to significant dehydration or electrolyte imbalances. Clinical monitoring of blood glucose and renal function is necessary following an accidental ingestion of a higher-than-prescribed amount.

AntidoteNo specific antidote exists for {{molecule}}.

Management is supportive and based on clinical presentation.

Dehydration
Assess the patient for signs of volume depletion and provide intravenous fluids if necessary.
Electrolytes
Monitor serum electrolytes, particularly potassium and sodium, and correct imbalances as needed.
Glucose Monitoring
Continue to monitor blood glucose levels to ensure they remain within a safe range.
Renal Function
Evaluate renal function through serum creatinine and eGFR measurements following the incident.

Safety and precautions

When to avoid Dapagliflozin

Do not take if you
  • Hypersensitivity

    Known allergy to dapagliflozin or any excipients.

  • Dialysis

    Patients on dialysis should not initiate or continue this therapy.

Use with caution
  • Severe Renal Impairment

    Efficacy is reduced in patients with severe kidney disease.

  • History of Ketoacidosis

    Increased risk of recurrence.

  • Volume Depletion

    Risk of hypotension in dehydrated patients.

  • Urinary Tract Infections

    May exacerbate active infections.

Safety at a glance

AlcoholUse with caution

Excessive alcohol consumption may increase the risk of ketoacidosis and hypoglycemia.

PregnancyUnsafe

Do not use during the second and third trimesters as it may affect fetal kidney development.

BreastfeedingConsult your doctor

Consult your doctor; it is not known if this drug passes into breast milk.

DrivingSafe

Usually safe, but be cautious if you experience dizziness or low blood sugar.

KidneyUse with caution

Dose adjustment may be required based on eGFR; monitor kidney function regularly.

LiverUse with caution

Use with caution in patients with severe hepatic impairment.

AllergyUnsafe

Do not take if you have a known hypersensitivity to dapagliflozin.

ChildrenUnsafe

Not recommended for use in children under 18 years of age.

ElderlyUse with caution

Increased risk of volume depletion and hypotension; monitor closely.

Interactions

With other medicines

Insulin secretagogues

Moderate

Changes the medicine’s effect

What can happen: Increased risk of hypoglycemia.

What to do: Consider reducing the dose of the secretagogue.

Loop diuretics

Moderate

Changes the medicine’s effect

What can happen: Increased risk of hypotension and dehydration.

What to do: Monitor blood pressure and hydration status closely.

Insulin

Moderate

Changes the medicine’s effect

What can happen: Higher risk of hypoglycemia and ketoacidosis.

What to do: Adjust insulin dose as per blood glucose monitoring.

With food and drink

  • High-sugar dietMinor

    May counteract the glucose-lowering benefits of the medication.

  • AlcoholModerate

    Increases the risk of ketoacidosis and hypoglycemia.

If you have another condition

  • Renal Impairment

    Requires dose monitoring and potential discontinuation if eGFR falls below threshold.

  • Hepatic Impairment

    Use with caution due to limited data in severe cases.

  • Hypotension

    May worsen blood pressure levels in patients already prone to low BP.

Effect on laboratory tests

  • Urine Glucose Test

    Always positive

    This is expected as the drug works by excreting glucose in urine.

  • 1,5-anhydroglucitol (1,5-AG) assay

    Unreliable

    SGLT2 inhibitors interfere with this test; do not use it to monitor glycemic control.

Quick tips

  • Monitor your blood glucose levels regularly as advised by your doctor.
  • Maintain good personal hygiene to reduce the risk of genital mycotic infections.
  • Drink adequate fluids throughout the day to prevent dehydration.
  • Report any signs of urinary tract infections, such as burning during urination, to your physician immediately.
  • Be aware of the symptoms of diabetic ketoacidosis, including nausea, vomiting, and abdominal pain, and seek help if these occur.
  • Inform your healthcare provider if you are planning any surgery or have a scheduled medical procedure.

Counselling points

  • Genital InfectionsImportant

    This medication increases the risk of genital fungal infections. Maintain good hygiene and contact your doctor if you notice symptoms.

  • HydrationImportant

    Drink plenty of water to prevent dehydration, especially in hot weather or during physical activity.

  • KetoacidosisImportant

    Seek medical help immediately if you experience unexplained nausea, vomiting, abdominal pain, or rapid breathing.

  • HypotensionGood to know

    You may feel dizzy when standing up quickly. Rise slowly from a sitting or lying position.

Monitoring during treatment

Before starting

  • Renal function (eGFR)
  • Blood pressure
  • HbA1c

During treatment

  • every 3 to 6 months: Monitor renal function and HbA1c levels.
  • as needed: Check for signs of genital infections or urinary symptoms.

What is being watched

  • eGFR
  • Serum creatinine
  • Blood glucose
  • HbA1c
  • Blood pressure

Pharmacokinetics

Absorption
Rapidly absorbed after oral administration.
Bioavailability
Approximately 78%.
Protein binding
About 91%.
Volume of distribution
118 liters.
Half-life
Approximately 12.9 hours.
Metabolism
Primarily via UGT1A9 glucuronidation.
Excretion
Mainly through urine as metabolites.
Onset / duration
Onset within 24 hours; duration covers 24 hours.

Fact box

Chemical class
C-glucoside
Habit forming
No
Therapeutic class
Antidiabetic agent
Action class
Glucose-lowering agent
Storage
Store Dapagliflozin 5mg Tablet at room temperature, away from moisture and direct heat. Keep the medication in its original packaging and out of reach of children.
ATC code
A10BK01
Pregnancy category
Category D

More information

Why Clinicians Prioritize SGLT2 Inhibitors

Clinicians increasingly favor Dapagliflozin as a first-line or early add-on therapy because it offers benefits that extend well beyond simple glucose reduction. Unlike traditional oral hypoglycemic agents that primarily target insulin resistance or secretion, Dapagliflozin addresses the renal handling of glucose. This unique mechanism provides a 'cardiorenal' protective effect, which has been validated in large-scale clinical trials. For patients with type 2 diabetes who also have established cardiovascular disease or chronic kidney disease, Dapagliflozin is often chosen because it actively reduces the risk of heart failure hospitalization and slows the progression of kidney damage, providing a holistic approach to managing the complex metabolic and systemic risks associated with diabetes.

Comparing Dapagliflozin with Traditional Alternatives

When compared to older classes like sulfonylureas, Dapagliflozin offers a significantly lower risk of hypoglycemia, as its action is independent of insulin levels. Unlike metformin, which is primarily a hepatic glucose regulator, Dapagliflozin works by promoting the excretion of glucose, which also leads to a modest reduction in body weight and blood pressure. While metformin remains the gold standard for initial therapy due to its safety profile and cost-effectiveness, Dapagliflozin is frequently introduced when patients require additional glycemic control or when they present with specific comorbidities like heart failure or reduced eGFR. It is not a replacement for insulin in type 1 diabetes, but it serves as a powerful tool in the modern management of type 2 diabetes and related organ dysfunction.

Lifestyle and Diet During Treatment

Taking Dapagliflozin does not eliminate the need for a healthy lifestyle. Patients are encouraged to maintain a balanced diet that is low in refined sugars and saturated fats to support the medication's glucose-lowering effects. Because Dapagliflozin induces a mild osmotic diuresis, staying well-hydrated is essential to prevent dizziness and orthostatic hypotension. Regular physical activity is also vital, as it enhances insulin sensitivity and cardiovascular health. Patients should be particularly mindful of foot care, as diabetes-related neuropathy can mask injuries, and the increased glucose in the urine can potentially create an environment conducive to skin infections if hygiene is neglected. Consistent monitoring of blood sugar levels remains a cornerstone of successful therapy.

What to Expect Over a Course of Treatment

Upon starting Dapagliflozin, patients may notice an increase in the frequency and volume of urination, which is a normal physiological response to the drug's mechanism of action. This effect typically stabilizes over time. Over the first few weeks, patients often observe a gradual improvement in their HbA1c levels and may experience a slight reduction in body weight. It is important to attend all scheduled follow-up appointments, as the clinician will need to monitor renal function and electrolyte balance, especially in the first few months. If any symptoms of genital discomfort or signs of urinary tract infection appear, these should be reported promptly to the healthcare provider. Long-term treatment with Dapagliflozin is generally well-tolerated and provides sustained protection for the heart and kidneys.

References

  1. Medicines.org.uk. Dapagliflozin 10mg Film-coated Tablets, Summary of Product Characteristics.View sourceAccessed
  2. European Medicines Agency. Dapagliflozin Viatris, Product Information.View sourceAccessed
  3. National Agency for Food and Drug Administration and Control. Dapagliflozin 10mg SmPC.View sourceAccessed
  4. Medical Products Agency Sweden. Dapagliflozin Reddy SmPC.View sourceAccessed
  5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019. p. 294, 301, 303.Accessed
Also available as

Frequently asked questions about Dapagliflozin

Can I take Dapagliflozin 5mg Tablet if I have kidney problems?

Yes, but your doctor will need to monitor your kidney function. It is generally not recommended if your eGFR is very low.

Does Dapagliflozin 5mg Tablet cause weight loss?

Many patients experience modest weight loss while taking Dapagliflozin due to the loss of glucose calories in the urine.

Is Dapagliflozin 5mg Tablet a form of insulin?

No, Dapagliflozin is not insulin. It works by helping your kidneys remove sugar from your blood through your urine.

What should I do if I feel dizzy?

Dizziness may be a sign of low blood pressure. Sit or lie down, drink water, and inform your doctor if the feeling persists.

Can I stop taking Dapagliflozin 5mg Tablet if my blood sugar is normal?

Do not stop taking the medication without consulting your doctor, as your blood sugar levels may rise again.

Latest